Recombinant or endogenous TSH for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of endocrinology"
DOI: 10.1093/ejendo/lvad006
Abstract: For patients undergoing radioiodine therapy of differentiated thyroid carcinoma (DTC), TSH stimulation prior to radioiodine therapy (RIT) can be achieved using thyroid hormone withdrawal (THW) or administration of recombinant human TSH (rhTSH). As THW can… read more here.
Keywords: thyroid; therapy; iodine; remnant ablation ... See more keywords
Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?
Sign Up to like & getrecommendations! Published in 2022 at "European Thyroid Journal"
DOI: 10.1530/etj-22-0084
Abstract: Objective To determine whether radioiodine remnant ablation (RRA) reduces cause-specific mortality (CSM) or tumor recurrence rates (TRR) after potentially curative bilateral thyroidectomy (BT) in low-risk adult papillary thyroid carcinoma (APTC) patients, we compared postoperative outcomes… read more here.
Keywords: radioiodine remnant; thyroid; adult papillary; rra ... See more keywords
TSH ≥30 mU/l may not be necessary for successful 131I remnant ablation in patients with differentiated thyroid cancer.
Sign Up to like & getrecommendations! Published in 2023 at "European thyroid journal"
DOI: 10.1530/etj-22-0219
Abstract: BACKGROUND Purpose To determine whether thyroid stimulating hormone level ≥30 mU/l is necessary for radioiodine (131I) remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC), as well as its influencing factors and predictors. METHODS… read more here.
Keywords: patients differentiated; differentiated thyroid; rra; remnant ablation ... See more keywords
Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with 131I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Nuclear Medicine"
DOI: 10.2967/jnumed.121.263442
Abstract: Visual Abstract It is well known that ionizing radiation can induce genetic damage and that oxidative stress is a major factor inducing it. Our aim was to investigate whether thyroid remnant ablation with low activities… read more here.
Keywords: hormone; damage; thyroid; dna damage ... See more keywords
A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol
Sign Up to like & getrecommendations! Published in 2020 at "Endocrinology and Metabolism"
DOI: 10.3803/enm.2020.681
Abstract: Background Radioactive iodine (RAI) remnant ablation is recommended in patients with papillary thyroid cancer (PTC) and extrathyroidal extension or central lymph node metastasis. However, there exists little evidence about the necessity of remnant ablation in… read more here.
Keywords: low intermediate; intermediate risk; remnant ablation; ablation ... See more keywords
Radioactive Iodine Remnant Ablation: The Beta-knife Completion Thyroidectomy
Sign Up to like & getrecommendations! Published in 2017 at "Molecular Imaging and Radionuclide Therapy"
DOI: 10.4274/2017.26.suppl.03
Abstract: The rationale and objectives for radioactive iodine (RAI) ablation remain perplexing to many. This review addresses the meaning, clinical context and the goals of “ablation”: the RAI treatment after a total thyroidectomy. This article also… read more here.
Keywords: radioactive iodine; ablation; iodine remnant; thyroidectomy ... See more keywords